Physician's group wants new drug labeling, 2-year DTC moratorium

Share this article:
The American College of Physicians (ACP) called for the FDA to be empowered to label newer drugs as such and to restrict consumer advertising of them.

In a policy paper titled Improving FDA Regulation of Prescription Drugs, the group, which claims a membership of 129,000 internal medicine physicians, related sub-specialists and medical students, said the agency needs more funding and greater powers. Among them, ACP argues that FDA should be authorized to require that new drugs carry labeling indicating their new-to-market status and that DTC advertising be restricted for the first two years a drug is on the market.

ACP also called for FDA to: increase their capacity to regulate drugs manufactured outside the US through appropriations and user fees; be given expanded authority in design of pre-approval trials and studies; ban “bundling of drugs that limits marketability and availability”; and improve the adverse events reporting system.
Share this article:

Email Newsletters

More in News

Star Group merges with Vox Medica, Calcium NYC

Star Group merges with Vox Medica, Calcium NYC

The newly formed group will be known as Calcium with Steve Michaelson, formerly of Rosetta Wishbone, at the helm.

Survey finds pay doesn't make doctors happy

Survey finds pay doesn't make doctors happy

Medscape's survey of over 24,000 physicians found that a paycheck is not necessarily linked to a physician's professional satisfaction.

CDC sees declines in some diabetes complications

CDC sees declines in some diabetes complications

Centers for Disease Control data shows that diabetes complications including heart attack and amputation fell in the twenty years between 1990 and 2010. The bad news: the number of diagnosed ...